The shift was significantly skewed for PDGFRα expression in tumour cells, which was up-regulated in lymph node metastases and recurrences, and for stromal PDGFRβ expression, which was down-regulated in recurrences (Table 2). This evidence concerns the gene PDGFRA and neoplasm.